Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2014 1
2019 3
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Bioequivalence Study of 100-mg Cilostazol Tablets in Healthy Thai Adult Volunteers.
Chatsiricharoenkul S, Nanchaipruek Y, Manopinives P, Atakulreka S, Niyomnaitham S. Chatsiricharoenkul S, et al. Among authors: niyomnaitham s. Curr Ther Res Clin Exp. 2019 Jul 15;91:11-16. doi: 10.1016/j.curtheres.2019.06.004. eCollection 2019. Curr Ther Res Clin Exp. 2019. PMID: 31372190 Free PMC article.
Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.
Niyomnaitham S, Toh ZQ, Licciardi PV, Wongprompitak P, Srisutthisamphan K, Copeland KK, Chokephaibulkit K. Niyomnaitham S, et al. J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.014. Epub 2022 Jun 18. J Infect. 2022. PMID: 35728642 Free PMC article. Clinical Trial. No abstract available.
Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study.
Sirijatuphat R, Manosuthi W, Niyomnaitham S, Owen A, Copeland KK, Charoenpong L, Rattanasompattikul M, Mahasirimongkol S, Wichukchinda N, Chokephaibulkit K. Sirijatuphat R, et al. Among authors: niyomnaitham s. Emerg Microbes Infect. 2022 Dec;11(1):2197-2206. doi: 10.1080/22221751.2022.2117092. Emerg Microbes Infect. 2022. PMID: 35997325 Free PMC article. Clinical Trial.
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination.
Chatsiricharoenkul S, Niyomnaitham S, Posen HJ, Toh ZQ, Licciardi PV, Wongprompitak P, Duangchinda T, Pakchotanon P, Chantima W, Chokephaibulkit K. Chatsiricharoenkul S, et al. Among authors: niyomnaitham s. Front Immunol. 2022 Oct 4;13:1010835. doi: 10.3389/fimmu.2022.1010835. eCollection 2022. Front Immunol. 2022. PMID: 36268028 Free PMC article.
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults.
Niyomnaitham S, Quan Toh Z, Wongprompitak P, Jansarikit L, Srisutthisamphan K, Sapsutthipas S, Jantraphakorn Y, Mingngamsup N, Licciardi PV, Chokephaibulkit K. Niyomnaitham S, et al. Hum Vaccin Immunother. 2022 Jul 11:2091865. doi: 10.1080/21645515.2022.2091865. Online ahead of print. Hum Vaccin Immunother. 2022. PMID: 35816053
11 results